Sunshine Biopharma (SBFM) EBT Margin Growth (3y) (2021 - 2026)
Sunshine Biopharma (SBFM) EBT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 1,840.00 |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -134.00 |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -5,626.00 |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -1,686.00 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -1,570.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 5,487.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -225.00 |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 1,846.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,846.00 |
| Dec 31, 2025 | 57,066.00 |
| Sep 30, 2025 | 108,624.00 |
| Jun 30, 2025 | 33,747.00 |
| Mar 31, 2025 | 99,427.00 |
| Dec 31, 2024 | -80,759.00 |
| Sep 30, 2024 | 800,682.00 |
| Jun 30, 2024 | 543,611.00 |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 385,549.00 |
| Sep 30, 2023 | 406,319.00 |
| Jun 30, 2023 | 597,706.00 |
| Mar 31, 2023 | 81,519.00 |
| Dec 31, 2022 | 316,641.00 |
| Sep 30, 2022 | 368,371.00 |
| Jun 30, 2022 | 395,289.00 |
| Mar 31, 2022 | 9.63 Mn |
| Mar 31, 2021 | -1.52 Mn |